Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Clinical trial NCT07578116 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07578116
Sponsor: SWOG Cancer Research Network
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic HER2-Positive Breast Carcinoma Oligometastatic Breast Carcinoma

Start date: 2027-03-09
Primary completion: 2032-05-31
Enrollment: 562

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.